Jin Soyeon, Kang Peter M
Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, 3 Blackfan Circle, CLS 910, Boston, MA 02215, USA.
School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA.
Antioxidants (Basel). 2024 Jul 29;13(8):923. doi: 10.3390/antiox13080923.
Oxidative stress plays a significant role in the pathogenesis of cardiovascular diseases, such as myocardial ischemia/reperfusion injury, atherosclerosis, heart failure, and hypertension. This systematic review aims to integrate most relevant studies on oxidative stress management in cardiovascular diseases. We searched relevant literatures in the PubMed database using specific keywords. We put emphasis on those manuscripts that were published more recently and in higher impact journals. We reviewed a total of 200 articles. We examined current oxidative stress managements in cardiovascular diseases, including supplements like resveratrol, vitamins C and E, omega-3 fatty acids, flavonoids, and coenzyme-10, which have shown antioxidative properties and potential cardiovascular benefits. In addition, we reviewed the pharmacological treatments including newly discovered antioxidants and nanoparticles that show potential effects in targeting the specific oxidative stress pathways. Lastly, we examined biomarkers, such as soluble transferrin receptor, transthyretin, and cystatin C in evaluating antioxidant status and identifying cardiovascular risk. By addressing oxidative stress management and mechanisms, this paper emphasizes the importance of maintaining the balance between oxidants and antioxidants in the progression of cardiovascular diseases. This review paper is registered with the International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY), registration # INPLASY202470064.
氧化应激在心血管疾病的发病机制中起着重要作用,如心肌缺血/再灌注损伤、动脉粥样硬化、心力衰竭和高血压。本系统综述旨在整合心血管疾病中氧化应激管理方面最相关的研究。我们使用特定关键词在PubMed数据库中搜索相关文献。我们重点关注那些近期发表且发表在影响较大期刊上的手稿。我们共审查了200篇文章。我们研究了心血管疾病中当前的氧化应激管理方法,包括白藜芦醇、维生素C和E、ω-3脂肪酸、类黄酮和辅酶Q10等补充剂,这些物质已显示出抗氧化特性和潜在的心血管益处。此外,我们还审查了药物治疗方法,包括新发现的抗氧化剂和纳米颗粒,它们在靶向特定氧化应激途径方面显示出潜在效果。最后,我们研究了生物标志物,如可溶性转铁蛋白受体、甲状腺素转运蛋白和胱抑素C在评估抗氧化状态和识别心血管风险方面的作用。通过探讨氧化应激管理及其机制,本文强调了在心血管疾病进展过程中维持氧化剂和抗氧化剂平衡的重要性。本综述文章已在国际注册系统评价和荟萃分析方案平台(INPLASY)注册,注册号为INPLASY-202470064。